tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD

Compare Tvardi Therapeutics (TVRD) vs. Competitors

Compare
2,529 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Tvardi Therapeutics
$4.23
$39.68M
-0.43
-70.32%
3 Buy
4 Hold
0 Sell
Moderate Buy
Plus Therapeutics
$0.58
$80.41M
-0.31
-51.25%
3 Buy
0 Hold
0 Sell
Strong Buy
Cue Biopharma
$0.34
$35.85M
-0.86
-72.97%
Aligos Therapeutics
$10.33
$63.57M
-0.52
-73.09%
3 Buy
0 Hold
0 Sell
Strong Buy
Genenta Science SpA Sponsored ADR
$1.45
$27.57M
-2.82
-71.71%
1 Buy
0 Hold
0 Sell
Moderate Buy
Adlai Nortye Ltd. Sponsored ADR
$1.47
$54.24M
-26.87%
0 Buy
1 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVRD
Tvardi Therapeutics
4.23
-9.75
-69.74%
PSTV
Plus Therapeutics
0.59
-0.55
-48.68%
CUE
Cue Biopharma
0.39
-0.95
-70.75%
ALGS
Aligos Therapeutics
10.33
-24.01
-69.92%
GNTA
Genenta Science SpA Sponsored ADR
1.44
-3.21
-69.03%
ANL
Adlai Nortye Ltd. Sponsored ADR
1.47
-0.51
-25.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts